Crossmark

Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants

Crossref DOI link: https://doi.org/10.1038/s41541-024-00950-9

Published Online: 2024-09-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vishwanath, Sneha https://orcid.org/0000-0001-9960-547X
Carnell, George William https://orcid.org/0000-0001-8875-0989
Billmeier, Martina

Ohlendorf, Luis

Neckermann, Patrick

Asbach, Benedikt

George, Charlotte https://orcid.org/0000-0002-6585-3288
Sans, Maria Suau

Chan, Andrew

Olivier, Joey

Nadesalingam, Angalee

Einhauser, Sebastian

Temperton, Nigel https://orcid.org/0000-0002-7978-3815
Cantoni, Diego

Grove, Joe

Jordan, Ingo https://orcid.org/0000-0003-2711-7252
Sandig, Volker

Tonks, Paul

Geiger, Johannes

Dohmen, Christian

Mummert, Verena

Samuel, Anne Rosalind

Plank, Christian

Kinsley, Rebecca

Wagner, Ralf

Heeney, Jonathan Luke https://orcid.org/0000-0003-2702-1621
License Information

Text and Data Mining valid from 2024-09-09

Version of Record valid from 2024-09-09
More Information

Article History

Received: 29 July 2023

Accepted: 14 August 2024

First Online: 9 September 2024

Competing interests

: R.K., R.W., and J.L.H. hold shares of DIOSynVax; R.K. is an employee of DIOSynVax. I.J and V.S are employees of ProBioGenAG, Berlin, Germany. J.G, C.D, V.M., A.R.S., C.P are employee of Ethris GmbH; Semmelweisstraße 3, 82152 Planegg, Germany. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

: All animal work was approved by the Home Office under project licence P8143424B and approved by the Animal Welfare Ethical Review Body (AWERB).

Document is current

Any future updates will be listed below